Sfoglia per Autore
Molecular determinants of the reduced cardiotoxicity of epirubicin
2005-01-01 Salvatorelli, E.; Guarnieri, S.; Menna, P; Cascegna, S.; Minotti, G.
Paclitaxel and docetaxel stimulation of doxorubicinol formation in the human heart: Implication for cardiotoxicity of doxorubicin-taxane chemotherapies
2006-01-01 Menna, Pierantonio
Defective one or two electron reduction of the anticancer anthracycline epirubicin in human heart: relative importance of vesicular sequestration and impaired efficiency of electron addition J. Biol. Chem
2006-01-01 Menna, Pierantonio
Paclitaxel and docetaxel stimulation of doxorubicinol formation in the human heart: Implications for cardiotoxicity of doxorubicin-taxane chemotherapies
2006-01-01 Salvatorelli, E; Menna, P; Cascegna, S; Liberi, A; Calafiore, Am; Gianni, L; Minotti, G
Defective one or two electron reduction of the anticancer anthracycline epirubicin in human heart: Relative importance of vesicular sequestration and impaired efficiency of electron addition
2006-01-01 Salvatorelli, E; Guarnieri, S; Menna, P; Liberi, G; Calafiore, Am; Mariggio, Ma; Mordente, A; Gianni, L; Minotti, G
An introduction to the metabolic determinants of anthracycline cardiotoxicity
2007-01-01 Menna, P; Recalcati, S; Cairo, G; Minotti, G
Doxorubicin degradation in cardiomyocytes
2007-01-01 Menna, P; Salvatorelli, E; Minotti, G.
Defective taxane stimulation of epirubicinol formation in the human heart: Insights into the cardiac tolerability of epirubicin-taxane chemotherapies
2007-01-01 Salvatorelli, E.; Menna, P.; Gianni, L.; Minotti, G
In vitro modelling of the structure-activity determinants of anthracycline cardiotoxicity.
2007-01-01 Menna, P.; Minotti, G; Salvatorelli, E.
Anthracyclines
2008-01-01 Minotti, G; Salvatorelli, E; Menna, P
Anthracycline Cardiotoxicity
2008-01-01 Menna, P.; Salvatorelli, E.; Gianni, L.; Minotti, G
Increasing doxorubicin antitumor activity through COX-2 inhibition without increasing cardiotoxicity
2008-01-01 Bianch, F; Campiglio, M; Sasso, M; Ghirelli, C; Tagliabue, E; Cairo, G; Salvatorelli, E; Minotti, G; Menna, P; Menard, S
Cardiotoxicity of antitumor drugs
2008-01-01 Menna, P; Salvatorelli, E; Minotti, G
Tumor necrosis factor alpha and cardiomyocytes: evidence for a self-protective preconditioning
2009-01-01 Cacciapaglia, F.; Menna, P.; Salvatorelli, E.; Buzzulini, F.; Arcarese, L.; Margiotta, D.; Minotti, G; Afeltra, A.
4’- Epidoxorubicin to reexplore anthracycline degradation in cardiomyocytes
2009-01-01 Menna, P; Salvatorelli, E; Minotti, G
Doxorubicinolone formation and efflux : A salvage pathway against epirubicin accumulation in human heart
2009-01-01 Salvatorelli, E; Menna, P; Lusini, M; Covino, E; Minotti, G
Translating molecular mechanisms into clinical facts
2010-01-01 Menna, P.; Salvatorelli, E.; Salsano, C.; Gianni, L.; Minotti, G
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis
2010-01-01 Cacciapaglia, F.; Menna, P.; Navarini, L.; Salvatorelli, E.; Lo Vullo, M.; Vernuccio, A.; Minotti, G; Afeltra, A.
Cardiovascular toxicity of antitumor drugs :Translating molecular mechanisms into clinical facts
2010-01-01 Menna, P.; Salvatorelli, E.; Salsano, C.; Gianni, L.; Minotti, G.
Anthracycline degradation in cardiomyocytes: a journey to oxidative survival
2010-01-01 Menna, P; Salvatorelli, E; Minotti, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile